Virbac has taken over the distribution of the prescription-only topical ectoparasiticide range, Activyl.
Activyl is available in three spot-on preparations: Activyl for Dogs and Activyl for Cats (flea control) and Activyl Tick Plus for tick and flea control in dogs. Based on the active ingredient indoxacarb, they are effective against developing flea life stages in the immediate environment of the pet.
Virbac Product Manager Kate Woolley MRCVS said: "Virbac is a global leader in parasitology and is using its knowledge and expertise to develop a portfolio of award-winning products. We are delighted to add Activyl to our range of parasiticides."
For more information, contact your Virbac Territory Manager.
The RCVS assessor’s report said: "The premises are genuinely state of the art, with all the space and equipment needed to provide a full multi-discipline referral service.
"The outstanding feature of this visit was the level of inpatient care, which is impressive with dedicated team leaders and thorough handovers for continuity of care, and the depth of knowledge of the clinical and nursing teams.
"Special mention must be made of infection control and inpatient modules in which all the award points available were obtained."
The assessor's report added: "You have all produced a centre to be proud of, and the feeling of pride and commitment of the team, came across very clearly. I wish you every success as your reputation grows."
Rebecca Lunn, operations co-ordinator at Paragon, said: "Pets always come first at Paragon so to receive four “outstanding” awards from the RCVS is a great compliment and achievement.
"Naturally we are delighted. It’s a real tribute to our entire team and our determination to deliver quality care, excellent service and a compassionate approach to ensure the best possible treatment for our animals.
"To achieve this, we have invested heavily, not only in the best, highly-experienced diplomates but also the most advanced specialist equipment within veterinary science.
"That level of commitment will continue on all fronts as we strive to be the very best we can be."
The award, which is sponsored by Zoetis, celebrates vets in the first eight years of their career who have shown outstanding care, dedication or success.
Nominees may have delivered exceptional care to a patient, made a positive contribution to their community or the wider veterinary profession, or shown their dedication to a cause.
Early career vets who are keen to demonstrate their ambition and dedication to the profession can also self-nominate for the award.
British Veterinary Association President Elizabeth Mullineaux said: “We know how hard all vets work to care for the UK’s animals and to protect both human and animal health and welfare.
"Our young and early career vets deserve to have their incredible work recognised and this award is an opportunity to highlight their compassion, skills and positive contribution to the profession.”
The winner will be announced on Thursday 16th October 2025 at the BVA Awards in London, where they will be awarded a prize package which includes £1,000, a year of free BVA membership and mentoring/engagement opportunity with Zoetis.
The deadline for entries is 9am on Monday 4th August 2025.
www.bva.co.uk/YVOTY
Photo: Last year's winner, David Charles.
According to a survey carried out by Pfizer, veterinary surgeons are generally upbeat about the business prospects for their practice this year, despite predicting a harsh economic environment for the industry as a whole in 2011.
The Pulse Survey of more than 400 practice owners and their senior management teams, which presents a snapshot of market sentiment, revealed that predictions for the veterinary market in general remained as gloomy as 2010. Over half (52%) of respondents believed that conditions for the industry would get more challenging.
However, the response from owners about their own practice's performance was more bullish with a third (34%) believing their prospects will improve.
Pfizer Business Consultant, James White, said: "Practices are right to remain cautiously optimistic about 2011 if we accept it's going to be a challenging year. Some practices came slightly unstuck in 2010 as a result of the knock-on effects of the economic downturn on pet owners' pockets. However, by implementing the correct strategies now there are still opportunities for growth. Client loyalty is the buzz word and should remain a key component of any practice strategy being implemented in the coming months."
Pfizer launched the Pulse survey in Autumn 2010 to deliver up to date analysis on a range of issues that senior management teams at practice level are witnessing. According to the company, the survey is attracting a growing volume of respondents. All participants receive a summary report of the Pulse Survey findings.
Pfizer's team of Business Consultants is working with practices throughout the country to pinpoint their individual business challenges, offer solutions through the company's Vet Support+ service and work with the practices to drive growth. For further information visit http://www.vetsupportplus.co.uk/.
The British Veterinary Association has reiterated its call for heightened vigilance following confirmation by AHVLA that Schmallenberg virus (SBV) has been detected on four sheep farms in Norfolk, Suffolk and East Sussex.
At this early stage the virus is understood to be vector-borne (although other routes of transmission have not been ruled out) and the clinical signs seen along with meteorological modelling of risk suggests that the four farms were affected during summer/autumn 2011, with congenital defects now becoming visible at lambing time.
Animals imported from the affected areas in northern Europe are also considered to be potentially at risk and their destination in the UK has been identified.
Congenital deformities and nervous defects are seen in newborn lambs, goat kids and calves. Clinical signs in affected cattle include pyrexia (fever), milk drop, and diarrhoea similar to what is often termed 'winter dysentery'. Farmers should be looking out for clusters of these signs within herds and flocks and reporting them to their veterinary surgeon.
Vets who are aware of suspicious clinical signs on their client's farms should report them to AHVLA, SAC or the local DARD divisional veterinary office for further investigation.
AHVLA, SAC and DARD have stated that they are keen to investigate potential cases and there will be no extra charge for the SBV tests that are undertaken, but their approaches are slightly different.
In England, Wales and Northern Ireland AHVLA and AFBI are carrying out SBV-only testing (ie to rule the disease in or out) free of charge but are charging the standard subsidised investigation charge for any additional diagnostic work.
In Scotland any carcases submitted for post mortem examinations are examined at the standard fee and all necessary examinations required by the VIO to investigate the case are included in the fee. SAC is not charging an additional fee for SBV testing.
Carl Padgett, President of the BVA, said: "The confirmation of Schmallenberg virus in sheep flocks in England is a reminder to vets and farmers across the UK to step up vigilance amongst ruminants.
"The BVA would encourage vets to speak to their local AHVLA, SAC or DARD team to discuss any suspect cases and consider submitting specimens for further investigation. We understand that in confirmed cases clinical signs occur in clusters and vets should ensure they know what to look for in both adult and perinatal ruminants.
"While the cases in the south east of England suggest the virus is vector-borne other potential routes of transmission are still being considered. Although the risk of zoonosis is believed to be very low it has not been ruled out and a sensible precautionary approach should be taken by those handling infected animals and specimens."
This, say the researchers, is the first time in a UK field setting that the effect of early-life exposures, in particular exercise and turn out, on later-life milestones and race performance in Thoroughbreds has been comprehensively evaluated.
The findings can be applied at stud farms to help retain Thoroughbreds within the industry and achieve their athletic potential - outcomes that align with priorities of the Horse Welfare Board’s strategy to support the welfare of horses bred for racing.
The research team, led by Rebecca Mouncey MRCVS, a Post-Doctoral Research Fellow at the RVC, followed 129 flat race bred Thoroughbred foals, born in 2019 and 2020 on six stud farms across the UK, from birth into training for racing.
Each dam’s reproductive history, and details of her health and management during pregnancy were collected, as were daily records of the foal’s health and management from birth until they left the stud farm.
Race performance records up to the end of their fourth year of life were collated from racing industry databases.
The team then used statistical modelling to evaluate relationships between gestational exposures and early-life experiences and whether or not horses entered training and their subsequent race performance.
Findings suggested that the use of more extensive turnout practices during the first six months of life and later weaning benefited the attainment of career milestones, productivity (the number of races) and financial returns (total prizemoney won).
The main findings were:
The findings demonstrate that the first six months of life is a critical period of development in Thoroughbreds, during which it is essential that turnout and weaning practices provide sufficient opportunity for positive tissue adaptation and optimal development.
Breeders are therefore encouraged to maximise turnout whenever possible, and to consider weaning after this critical period.
https://www.rvc.ac.uk/research/projects/veeph/early-life-determinants-of-performance-and-the-economics-of-thoroughbred-breeding
Reference
The Royal (Dick) School of Veterinary Studies has become the first place in the UK to offer reptile training recognised by the European College of Zoological Medicine.
Kevin Eatwell, who is part of the School's Exotic Animal and Wildlife Service, has been awarded diplomat status by the European College of Zoological Medicine (ECZM).
This will enable him to offer training to residents at the School wishing to gain European accreditation in the area of herpetology, which covers reptiles.
The Royal (Dick) School of Veterinary Studies, which is part of the University of Edinburgh, also gained the endorsement of the ECZM to train residents to treat reptiles following a visit by its president.
The diplomat status recognises Mr Eatwell as a specialist in Europe. In addition, he is also one of only two RCVS diploma holders in reptile medicine in the UK.
To qualify as an ECZM diplomat a vet needs to meet stringent criteria. This includes the time spent specialising in a particular field as well as three first author and a minimum of three second co-author publications relevant to the specialty.
Many of Mr Eatwell's scientific papers followed on from a dissertation, which was funded through an educational grant through the RCVS Trust.
As a diplomat for the European College of Zoological Medicine, Mr Eatwell will input into the ECZM training criteria for vets specialising in the care and treatment of reptiles.
Mr Eatwell said: "I am delighted to have achieved such status by the European College of Zoological Medicine. It is very exciting to be involved in the education of specialist veterinary surgeons throughout Europe. This will also open the door for residents at the Royal (Dick) School of Veterinary Studies to obtain European qualifications relating to the specialist treatment of reptiles."
Mr Eatwell is one of only a handful of ECZM diplomats in the UK and the first in herpetology. Other ECZM diplomats cover disciplines including avian, small mammals and wildlife and conservation.
Cherry Bushell, Director of the RCVS Trust, said: "It's always wonderful to hear that the grants awarded by RCVS Trust do help make a difference to young vets and to the development of animal care in the UK and overseas. We congratulate Kevin on his achievement and wish him every success in the future."
The Royal (Dick) School of Veterinary Studies also has the UK's first European resident in Small Mammal Medicine, Elisabetta Mancinelli, who is being supervised by Anna Meredith, head of the Exotic Animal and Wildlife Service.
'Get Well Friends', a new retail opportunity for veterinary practices, has now officially launched with a new website: www.getwellfriends.com
Described by their inventor, childrens' author Kes Gray, as "the ouch factor mixed with the aah factor", Get Well friends are a new and unique range of soft toy poorly animal characters for veterinary surgeries to sell. Each character is as cute as it is accident prone, and comes complete with a prescription from mouse Nurse Nibbles.
"For all kinds af reasons a young child may have to leave their pet with a vet. Under such circumstances, they can now depart from the surgery with a soft toy animal character that they themselves can nurse back to good health."
The Get Well Friends.com website has been set up to try and lower the blood pressure of long suffering veterinary waiting room staff, with online games for children to play and activity sheets for surgeries to print off.
First shown at the London Vet Show, the current gift range comprises 5 soft toy characters and a 'childrens picture book entitled 'Who's Poorly Too?' The recommended retail price for each 8" soft toy characters is £11.99. (Trade price £5.50 per unit not inclusive of Vat.) The 'Who's Poorly Too' paper back picture book has an RRP of £5.99 and a trade price of £3.60 per unit.
Kes Gray's wife and co-founder of Get Well Friends said: "The spinner is our recommended display method. It has a strong and colourful retail presence. It holds fifteen toys and fifteen picture books, and can be bought for a special intoductory offer price of just £157.50. If a surgery waiting room is pushed for space, we can offer our striking 10 unit counter display boxes, or if preferred we can supply any combination of characters loose."
Click here to download the brochure and trade price list.
If you would like to place an order or make an enquiry contact Kes & Claire direct at info@getwellfriends.com.
The Department for Environment, Food and Rural Affairs (Defra) and the Food Standards Agency (FSA) are reminding veterinary surgeons of their legal responsibilities under the Horse Passport Regulations 2009.
The move follows a small number of horses testing positively for the presence of phenylbutazone, which, if consumed, can be harmful to human health.
Defra and the FSA have asked for the assistance of the profession in ensuring that treatment with phenylbutazone is properly recorded in Horse Passports and have said that they are working together to understand the cause of the positive tests, and what longer term measures can be put in place to stop this happening.
In the interim, all horses slaughtered for human consumption will be sampled for the presence of phenylbutazone, with immediate effect.
The letter from Defra and the FSA can be downloaded from the RCVS website.
The full advice can be read in a Veterinary Medicines Directorate/Defra leaflet, which can be found online at http://www.vmd.defra.gov.uk/pdf/leaflet_horses.pdf.
Mark Bowen, Chair of the British Equine Veterinary Association's Health and Medicines Committee, said: "The number of horses entering the human food chain from the UK has doubled since 2009 and is no longer an insignificant minority of horses. All vets should be checking horse passports and only dispensing sensible quantities of this drug, and its prodrug suxibuzone."
Meanwhile, a form is available from the British Equine Veterinary Association website for veterinary surgeons to use if the horse passport is not available, but emergency treatment is required: http://www.beva.org.uk/_uploads/documents/emergency-treatment-form-no-passport-2011.pdf
The response from Scotland’s Cabinet Secretary for the Rural Economy and Connectivity, Fergus Ewing MSP, which was also sent on behalf of Scotland’s Cabinet Secretary Roseanna Cunningham MSP, said that:
"The First Minister is seeking guarantees from the UK Government that the residency status and other existing rights of the 173,000 EU citizens living in their respective countries will remain unchanged now and in the future."
This point was echoed in a response from Wales’ Cabinet Secretary for Environment and Rural Affairs, Lesley Griffiths AM, who said:
"The First Minister has also made it clear there are many sectors of business, which depend on EU citizens to fill vital posts and damage to public services and the wider economy would be immense if EU citizens were required to leave the country. I appreciate this could cause difficulties in relation to the veterinary profession and delivery of our Animal Health and Welfare programmes and policies in Wales."
Similarly, the Northern Ireland Minister of Agriculture, Environment and Rural Affairs, Michelle McIlveen MLA, acknowledged the vital contributions EU citizens make to animal health and welfare, saying:
"I will also endeavour, given the importance of animal and veterinary public health to the local economy, to ensure that this concern [you raise] is represented in the composite Northern Ireland input into the final United Kingdom negotiating position and strategy."
The new Secretary of State for Environment, Food and Rural Affairs, Andrea Leadsom MP, has offered to meet with BVA President Sean Wensley to discuss these and other priority issues for the veterinary profession.
BVA is establishing a Brexit working group to prioritise and develop policies on the key issues that should be raised in forthcoming discussions and negotiations.
The Royal Veterinary College and The Donkey Sanctuary have launched WikiDonkey, a new information resource about donkeys for veterinary surgeons, nurses and students.
According to The Donkey Sanctuary, WikiDonkey is the first site of its kind and will provide the most comprehensive source of accurate, research-led, practical and regularly-reviewed donkey veterinary information on the web.
WikiDonkey covers all the common conditions of donkeys and identifies the major differences between the management and treatment of donkeys and horses. The site also provides a set of normal physiological, biochemical and haematological parameters, resources that have not always been easily accessible but will undoubtedly prove essential for those treating donkeys.
The Donkey Sanctuary's veterinary project and development manager, Faith Burden said: "When we were approached by WikiVet to sponsor and provide content for their donkey section we were happy to support the initiative as it offers an excellent medium for us to share our expertise with others. We are pleased that these pages will allow veterinary professionals access to the most up-to-date information on donkey specific ailments and treatments."
Nick Short, head of the eMedia unit at the RVC said: "I believe that this unique resource will become an invaluable reference source for vets not only in the UK but all over the world. It will also help ensure that future generations of veterinary students will have access to a reliable and extensive knowledgebase on donkey health and welfare."
To view the Donkey Sanctuary's WikiVet pages, visit http://www.wikivet.net/ or to find out more about the work of The Donkey Sanctuary visit http://www.thedonkeysanctuary.org.uk/
Expert speakers at Advances in Diagnostics, a meeting held in Brussels last month, have said that molecular technology will play a vital role in safeguarding the health and productivity of food animals in the future.
Dr Willie Loeffen, President of the European Association of Veterinary Laboratory Diagnosticians (EAVLD) said: "Technology is taking over. Laboratory diagnosis used to be 99% labour and 1% technology, nowadays the emphasis is the other way around. Technology is now an integral and indispensable part of veterinary laboratories."
Dr Loeffen used the investigation of PRRSV infection in pigs and the more recent appearance of Schmallenberg virus in Europe to highlight how modern molecular techniques could help to characterise new disease threats rapidly.
"It took four years of laborious work for us to characterise the cause of PRRS, but thanks to sequencing technology Schmallenberg virus took just a few months.
"Technological developments mean that diagnosticians now do things that they could only dream about 10 or 20 years ago."
As well as providing a means of identifying new disease threats quickly, the meeting highlighted the increasing role of diagnostic tools as an integral part of maintaining animal health.
Dr Kirk Adams, Director of Product Management at Life Technologies, the meeting sponsor, said: "Diagnostics are no longer just a way of finding out what an animal died of - they have a multitude of uses on farm. They mean that we can take a more holistic and proactive approach to animal health; in contrast to the reactive, disease-driven approach of the past.
"As just one example, better diagnostics allow a more targeted approach to treatment, and the potential to reduce the use of broad-spectrum drugs - such as certain antibiotics - and thus comply with the wishes of consumers and legislators."
Dr Adams said that modern diagnostic tools also provided the means to improve vaccination programmes and biosecurity, and were essential for disease eradication schemes and for improving herd health status, for example by identifying persistently infected, asymptomatic animals.
They also enable veterinary surgeons to monitor herd health and build up an accurate and dynamic picture of health status and risk profile - and screen for emerging disease threats.
Dr Adams added: "Veterinarians now have access to a wider range of better diagnostics than ever before. Tests are now faster, more accurate and more precise than ever before.
"The next twenty years could see the biggest change in the way we manage production animals in over a hundred years."
The meeting was also addressed by Dr Kees van Maanen, from the Netherlands Animal health Service (GD), an expert in modern diagnostic technology and its application on both local and national levels. He called for greater international co-operation to protect European animals against threats from increasing global interaction. He said: "Pathogens and insects do not respect borders: trusting each other's results requires further harmonization and transparency for diagnostic procedures between laboratories and countries.
"Rapid and accurate diagnosis contributes to disease management, but does not stop epidemics. However, it has contributed significantly to gaining insight into the epidemiology of emerging diseases and formulating appropriate measures.
"The development of modern diagnostics has given us the potential to manage animal health and control infectious diseases in production animals far more effectively in the past - both on a local level and a national or regional level. Recent experience with unexpected disease outbreaks has shown that we can now characterise and track pathogens far more quickly and accurately than ever before.
"However, we need to make sure that we keep veterinarians and farmers informed about these developments, so they know how to apply them in practice in order to make the most of them.
"Diagnostics will continue to become a more integral part of animal health management in the next decade, we just need to make sure we can apply that knowledge in the best possible way."
Pfizer Animal Health is reminding horse owners of the importance of treating encysted small redworm larvae this autumn.
According to the company, these hidden, dormant parasites can account for up to 90% of the redworm burden in a horse (1). Furthermore, encysted small redworm larvae won't show up in a faecal egg count (FEC). Even if a horse has shown a negative or low count it could still be harbouring several million harmful larvae, hidden within the gut wall (2)
Encysted small redworm are a potential time bomb, with the ability to survive inside a horse for up to two years. They usually 'wake-up' in the late winter or early spring, developing and emerging from the gut wall all at the same time. Such a sudden mass emergence can cause a disease syndrome known as 'larval cyathostominosis', causing diarrhoea and colic with up to a 50% mortality rate (2). Treating encysted small redworm successfully in the late autumn or early winter is vitally important in order to prevent this serious risk.
Pfizer says that Moxidectin, the key ingredient of EQUEST, is recognised as the only single dose treatment for encysted small redworm. It has been shown to kill the larvae in-situ, without resulting in severe inflammation of the gut wall that other multi-dose treatments may cause (3). In addition, Moxidectin is licensed for persistent activity against small redworm over two weeks, killing larvae ingested as the horse grazes for up to two weeks after treatment.
Ben Gaskell, Pfizer's veterinary advisor said: "A responsible and sustainable worming programme involves good pasture management, regular diagnostic tests and targeted worming, carefully planned using specialist advice. However, it is also vital to remember the danger of encysted small redworm. Even if a horse's FEC is clear, there could still be a significant encysted small redworm burden that must be treated properly every year in late autumn / early winter."
1) Bairden K. et al (2001) Veterinary Record 148, 138-141 2) Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑242 3) Steinbach T. et al (2006) Veterinary Parasitology 139, 115‑131
The University of Nottingham, with funding worth £2.2m, is to carry out a study of the most common cause of Bovine Mastitis in the UK - Streptococcus uberis (S. uberis). If researchers can identify which parts of the bacteria enable the infection their results could lead to the production of an effective vaccine.
James Leigh, Professor of Molecular Bacteriology, who has recently joined the School of Veterinary Medicine and Science, said: "We hope to uncover bacterial antigens of potential use in vaccines aimed at preventing bovine mastitis and provide a detailed understanding of how animals can fight off the disease."
S. uberis is responsible for a significant proportion of clinical mastitis worldwide - but unlike many other bacteria that cause the disease, S. uberis is also in the environment - it is found in pasture and bedding and can even colonise the cow at other body sites with no ill effect - so it is difficult to see how it can be controlled by changes to animal husbandry and milking-time hygiene.
With funding from the Biotechnology and Biological Sciences Research Council (BBSRC) the School of Veterinary Medicine and Science has established research laboratories at the Institute for Animal Health (IAH). The project is being conducted in collaboration with Dr Tracey Coffey's Bovine Genomics group based at IAH and other groups at the Royal Veterinary College, the US Department of Agriculture in the UK and the University of Oxford.
Professor Leigh said: "We will use state-of-the-art molecular technology to determine the differences between strains of S. uberis that can and cannot cause disease. Proteins that are only present in the disease causing strains hold the key to determining which components are essential for infection. We will show which of these proteins are most likely to make an effective vaccine by producing strains of S. uberis which lack the ability to produce each of these proteins; if a strain lacking a particular protein is less able to cause disease then this protein is important for the disease process and becomes a candidate for vaccine development."
The team also want to identify any parts of the immune response in the dairy cow which can be altered to prevent the disease - this information could subsequently be used to develop drugs that interfere with the chemical messages that lead to inflammation and therefore reduce the level of disease.
A three-year scholarship for a residency in Rabbit and Exotic Animal Medicine and Surgery has been announced by the University of Edinburgh's Royal (Dick) School of Veterinary Studies.
Based at the only veterinary school in the UK to have a dedicated Exotic Animal and Wildlife Service (EAWS), the post will be jointly funded by Dechra Veterinary Products and Companion Care (Services) Ltd.
The Resident appointed is qualified veterinary surgeon Jenna Richardson, who will undertake training and research over three years and undertake the RCVS CertAVP in Zoological Medicine. Jenna graduated from the veterinary school in 2008.
Head of EAWS, Dr Anna Meredith MA, VetMB, CertLAS, DZooMed, MRCVS, said the collaboration between the veterinary school and the companies would support work to increase the amount of information available to vets, to improve treatments for pet rabbits and exotics. She said: "The main focus of the residency programme will be on advancing clinical practice in the field of rabbit and exotic animal medicine, and disseminating this to the profession. Jenna will be involved in EAWS' ongoing outreach programme to veterinary practices and to rabbit and exotic pet owners to promote animal health and welfare.
"We are extremely grateful to both Dechra Veterinary Products and Companion Care Vets for committing the funding to support this important work in a rapidly expanding field for the veterinary profession."
Dechra Veterinary Products' Brand Manager Carol Morgan said: "We are delighted to be jointly funding this scholarship, with the work to advance clinical practice fitting well with our own commitment to developing services and products which support the veterinary profession."
Jane Balmain, Companion Care Vets' Managing Director, added: "The residency has been created because of the increasing popularity of rabbits and exotics as pets and both Dechra and Companion Care wish to support this growing field whilst providing vital support for the University of Edinburgh."
The Dechra/Companion Care Residency in Rabbit and Exotic Animal Medicine and Surgery will also see the Resident's duties include diagnostic and medical management of cases; anaesthetic and surgical management of cases and radiography and ultrasonography imaging.
Pets’n’Vets has announced that it is burying a veterinary time capsule under its new Roundhouse Veterinary Hospital being built on the southside of Glasgow.
Brainchild of Pets’n’Vets partner Ross Allan, the idea is that the capsule will reveal to future generations how the cutting edge veterinary facility in Glasgow looked in 2015 and help show just how far veterinary science has developed when it is opened in 2115.
Ross said: "The aim of the time capsule is to document the memories, hopes and dreams of our staff at this exciting point in our story, and preserve them as best we can for discovery in 100 years."
The capsule, which was curated with help from The Veterinary History Society and the British Library, contains:
Ross said: "As an orthopaedic surgeon, I’m used to dealing with cutting edge metal plates, screws and pins when fixing fractured legs, but helping develop this capsule was an entirely new challenge for me. It is very rewarding to use great science to preserve these memories as best we can.
"The time capsule has been designed with this in mind: maintaining optimal humidity, zero oxygen and steady temperature. It will be welded shut before being flushed with argon gas, all measures to help preserve the photos, letters and other contents for those that are lucky enough to open it."
In order preserve the contents as best as possible, Ross sought the advice of Glasgow Museums, which advised including archive quality paper and ink to prevent fading of writing and images, as well as the use of corrosion bags to contain the metallic surgical implants.
"I thought it would be fun to include the implants we currently use for cruciate surgery," said Ross. "This is one aspect of veterinary surgery that has especially progressed over the last 30 years and will doubtlessly continue to progress in the years ahead."
David Thomson, Preventative Conservation Officer, Glasgow Museums, added: "Sending things safely into the future is very like preserving the collections we have in the Museum. The Veterinary Time Capsule meets the highest standards for slowing down the normal ageing effects of our environment and we wish it well on its journey through time."
The time capsule has been registered with the International Time Capsule Society (ITCS) at Oglethorpe University, Atlanta, USA.
Ross said: "This will ensure the capsule is followed up and not, like the majority, lost forever," said Ross. "When opened, the contents should offer a snapshot into Scottish 21st Century veterinary medicine and perhaps it can offer a small legacy to the future of veterinary medicine too.
"Veterinary medicine is going through a huge transition at present – the scope of what is available today is poles apart from what was possible even 10 years ago – and we are delighted to help document its development in Glasgow to this point. Just what might be possible when the capsule is opened in 2115 is mind boggling!"
Everyone who takes part in the survey, which is also open to nurses, practice support staff and veterinary students, will be entered into a free prize draw for the chance to win a 1 of 3 Amazon gift vouchers (up to the value of £200).
Lizzie Erian-Round, Head Veterinary Healthcare Advisor at Pegasus (pictured right) said: "With lockdown measures easing, it is a good time to take a deeper dive into what the future looks like. And importantly, how veterinary professionals feel about it. No one has a crystal ball but those on the veterinary frontline are already getting a sense of what could lie ahead. And we believe it’s important they get to share their view of what good support and communications look like.
Our last wave of research indicated that COVID-19 could be a major catalyst for future digital innovation and have lasting consequences for the way we practice. With that in mind we’ve focussed our new survey to be more forward facing."
Pegasus's last survey found that 84% of veterinary professionals thought that the coronavirus pandemic would change the way veterinary practices operate in the future. 78% thought more owners will buy their medicines online. 71% worried about their exposure to coronavirus at their work place and 68% worried about the impact of the pandemic on their mental wellbeing.
The survey closes at 9am GMT Tuesday 30th June The results will help animal health companies better understand how to best support and communicate with the veterinary profession beyond the pandemic.
To take part in the survey, visit: https://www.surveymonkey.co.uk/r/DRWSNWT
For a copy of the results, which will be available in July, email: animal@thisispegasus.co.uk.
The course offers practical tips and is also designed to help vets understand their obligations under the Code of Professional Conduct when discussing costs with clients.
RCVS CEO Lizzie Lockett said: “Discussions around the costs of veterinary treatment are not always easy and can sometimes give rise to misunderstandings or lack of clarity between clients and veterinary teams.
"We recognise the challenges these conversations present and the pressures veterinary professionals face.
“Meanwhile, the ongoing Competition and Markets Authority (CMA) investigation has highlighted that animal owners are not always satisfied with the level of information they receive in order to make an informed choice about treatment options.
This course supports the development of veterinary surgeons’ and veterinary nurses’ communication skills so that they can discuss treatment costs more transparently with their clients, helping to reduce potential misunderstandings and build trust.”
The course takes 45 minutes to complete and features an interactive scenario as well as expert video advice from experienced veterinary surgeons.
https://academy.rcvs.org.uk
A mutation responsible for Primary Lens Luxation (PLL), a painful and blinding inherited eye condition, has been indentified by geneticists working in the Kennel Club Genetics Centre at the Animal Health Trust. They expect a DNA test to identify carriers of the mutation to be available by late October, 2009.
The team led by Dr Cathryn Mellersh, in collaboration with Dr David Sargan (Cambridge University) and Dr David Gould (Davies Veterinary Specialists), believe the discovery could prevent the development of PLL in several breeds of terriers.
Miniature Bull Terriers, Lancashire Heelers, Tibetan Terriers, Jack Russell Terriers, Parson Russell Terriers, Patterdale Terriers, Sealyham Terriers and Chinese Crested dogs will all benefit from the findings.
Dr Cathryn Mellersh, said: "This is an exciting discovery for many breeds of dogs across the world. We have identified the mutation, and soon we'll be able to give advice on breeding strategies. Hopefully in time we'll eradicate this awful condition from many breeds of dogs."
In the near future a simple test kit will be available for breeders and owners to test their dogs. It will be possible to collect DNA from a simple cheek swab.
The DNA test will enable breeders to ascertain the likelihood of each dog's risk of developing PLL. Breeders will then be able to make informed decisions about which dogs to breed. This will minimise the risk of producing dogs that will become affected by the serious and debilitating condition.
In affected dogs PLL causes fibres which support the lens to breakdown or disintegrate, causing the lens to fall into the wrong place in the eye. Depending on where the lens falls, it can cause glaucoma or loss of vision.
Caroline Kisko, Communication Director at the Kennel Club, commented: "This is truly a major breakthrough at the Kennel Club Genetics Centre in our fight to eliminate many of the inherited diseases dogs have, all made possible with funding from the Kennel Club Charitable Trust.
"PLL is a painful and blinding condition, and we hope once the DNA test is available at the end of next month we will be able to eliminate this condition altogether."
Dr. Mellersh, added: "We would like to sincerely thank all the owners and breeders who have contributed DNA and information from their dogs to this project. The discovery would not have been possible without them."
The completion date for the RCVS surveys of the veterinary and veterinary nursing professions is Monday 8 February, and the College is urging anyone who has not yet completed their survey to do so.
The data collected will be used to help develop policy, in discussion with government and other bodies, and in response to requests from journalists and members of the public who wish to have an accurate picture of the veterinary profession today. So it's important that as many people as possible complete their surveys.
For the first time, a standard set of questions about well-being (the Warwick-Edinburgh Mental Well-Being Scale) has been included. Over time, data collected will enable the College to monitor population changes in mental health and well-being, and work with other organisations to address any issues identified.
If you have mislaid your paper copy, the survey can be completed online:
Veterinary surgeons click here: www.employmentresearch.co.uk/vs2010.htm
Veterinary nurses click here: www.employmentresearch.co.uk/vn2010.htm
All responses are confidential.
Royal Canin has introduced Feline Satiety Support diet in 1.5kg and 3.5kg bags to complement the existing packs of 28 sachets.
Royal Canin veterinary support manager Lepha McCartan said: "As every vet and vet nurse knows, obesity is an ever-increasing problem in cats. We have found that once owners are used to the idea of portion control provided by the existing 28 sachet packs, they are happy to continue to help get their cat's weight down. Bigger packs offer more convenience and value for money for the customer, particularly those who have a few cats with weight issues."
Royal Canin says Feline Satiety Support helps cats feel fuller for longer, offering a greater food volume compared to standard diets. A satisfied cat is less inclined to beg for food, which in turn helps prevent owners giving in to demands from a complaining cat. According to the company, vets recommending Feline Satiety Support have found that the sachet packs help owners understand the correct amount of kibbles per meal, and once this has been established the larger packs offer owners greater choice.
Feline Satiety Support is available in packs of 28 x 20g sachets and 1.5 and 3.5kg bags from all veterinary wholesalers. For more information, contact your Veterinary Business Manager or visit http://www.royalcanin.co.uk/.
Virbac has announced the launch of Canigen Lepto4 vaccine, which covers an additional two strains of Leptospirosis over its existing Canigen Lepto2 vaccine.
The company says the new product is designed to give practices the flexibility to meet the needs of certain high-risk groups in the UK and in dogs which may be travelling abroad.
Both vaccines are offered with technical training and support from Virbac. This includes a suite of educational and promotional resources to enable practices to engage with their clients and help to make informed decisions about Leptospirosis vaccination for their dog.
Sarah Walker MRCVS, Product Manager, said: "We are committed both to providing our practices with a full and flexible range of canine vaccines and to offering them all the support they need to advise their clients effectively on this important issue.
"While Canigen Lepto2 is still perfectly suitable in many cases and provides a broad spectrum of protection, the launch of Canigen Lepto4 helps to offer a solution for those who may needed a broader degree of protection through being at a higher risk or those which travel abroad."
The new platform offers video tutorials, podcasts, webinars, scientific studies, blogs and downloadable resources, all designed to ensure users understand how the HT Vista screening device can support their day-to-day work.
Users can also ask for a free one-on-one training call with HT Vista for personalised guidance.
HT Vista’s Managing Director, Liron Levy-Hirsch said: “We’re excited to introduce this new platform for veterinary professionals alongside our latest diagnostic update to the device.
"Our goal with HT Vista Academy is to support users in expanding their expertise, not just in operating the device but also in understanding the technology behind it and learning the best practice of dermal and subcutaneous mass management.
"By offering valuable educational resources and hands-on support, we hope to enhance the overall experience for veterinary teams and, ultimately, the care they provide to their patients.”
The company says the screening device is being widely used in nurse clinics around the world and its academy is suitable for both vets and veterinary nurses.
www.ht-vet.com/academy
Pfizer has released the results of its first Performance Index (formerly the Fort Dodge Index) which shows mildly improved trading conditions for the companion animal veterinary market in the first quarter of 2011.
Those aspects of veterinary business that showed an improvement in the first quarter of 2011 include: turnover growth (+0.8%, up from -0.1% in March 2010); client retention (+0.1%); the average number of visits per year (+ 0.17%); annual transaction value (+ 1.1%); average transaction value (+0.8% to £41.74); fee per product service (+0.2%) and products and services sold per visit (+0.6%).
Leveraged sales (typically pet-care products), which were down 2% (from 40% to 38%) in 2010, have increased 0.9% in the first quarter of 2011 to make up 39% of practice transactions.
Less positively and pointing to the need for veterinary practices to implement ongoing marketing initiatives, the number of new clients coming into practice is down (-0.4%) as is the number of active clients (-0.26%). Revenue from loyal clients (those that visit the practice for additional products and services, particularly vaccination and other preventative healthcare programmes) was static. Although flat growth is an improvement on previous reports, this is still a concern, as it is these clients who are the driver for revenue growth in many practices.
Pfizer Business Consultant, Simon Fowler said: "Although the figures are only very slightly improved this does mirror what we are seeing in practices that we visit. Practice turnover growth of 0.8%, while only small, is much better than any quarter in 2010. So we may be seeing the first green shoots of recovery, but there's still no room for complacency. Before we all breathe a collective sigh of relief, however, it should be remembered that as this is the first report for 2011 it is only an early picture, while a fuller story will be gleaned from the second report, which will show results from the first six months of the year.
"What is clear is the need for practices to market themselves in order to attract new clients, increase growth from active clients and increase client loyalty. VetSupport+ includes a range of marketing services to help practices in this respect. A practice has already achieved TV coverage via our Public Relations support service, while others are using PressRoom newsletter templates to keep potential and existing clients up to speed with the practice's news."
Further information about Pfizer's VetSupport+ service is available at www.vetsupportplus.co.uk.
The research aims to establish:
To take part in the survey, which takes between 10 and 15 minutes, click here.
Photo: I, Flukeman